These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 178047)

  • 1. Transfer factor treatment of patients with multuple sclerosis. I. Preliminary report of changes in immunological parameters.
    Jersild C; Platz P; Thomsen M; Dupont B; Svejgaard A; Ciongoli AK; Fog T; Grob P
    Scand J Immunol; 1976; 5(1-2):141-8. PubMed ID: 178047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term transfer-factor treatment for multiple sclerosis.
    Fog T; Pedersen L; Raun NE; Kam-Hansen S; Mellerup E; Platz P; Ryder LP; Jakobsen BK; Grob P
    Lancet; 1978 Apr; 1(8069):851-3. PubMed ID: 76798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity to viral antigens and tuberculin in multiple sclerosis.
    Sagar HJ; Allonby ID; Hughes P
    Acta Neurol Scand; 1981 Feb; 63(2):81-98. PubMed ID: 6259870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell mediated immunity to viral antigens in multiple sclerosis.
    Zabriskie JB; Espinoza LR; Plank CR; Collins RC
    Acta Neurol Scand Suppl; 1977; 63():239-51. PubMed ID: 265669
    [No Abstract]   [Full Text] [Related]  

  • 5. Viral antibodies in multiple sclerosis.
    Norrby E
    Prog Med Virol; 1978; 24():1-39. PubMed ID: 704893
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed lymphocyte culture determinants, measles infection and multiple sclerosis.
    Platz P; Dupont B; Fog T; Ryder L; Thomsen M; Svejgaard A; Jersild C
    Proc R Soc Med; 1974 Nov; 67(11):1133-6. PubMed ID: 4140520
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immunity in multiple sclerosis.
    Espinoza LR; Ebers G; Mountcastle W; Zabriskie JB
    Acta Neurol Scand Suppl; 1977; 63():123-31. PubMed ID: 265663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
    Collins RC; Espinoza LR; Plank CR; Ebers GC; Rosenberg RA; Zabriskie JB
    Clin Exp Immunol; 1978 Jul; 33(1):1-11. PubMed ID: 361313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to measles virus in multiple sclerosis: correlation with disability.
    Symington GR; Mackay IR
    Neurology; 1978 Feb; 28(2):109-12. PubMed ID: 202889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Letter: Suppressed cellular immunity to measles antigen in multiple-sclerosis patients.
    Utermohlen V; Zabriskie JB
    Lancet; 1973 Nov; 2(7838):1147-8. PubMed ID: 4128034
    [No Abstract]   [Full Text] [Related]  

  • 11. The HLA system and multiple sclerosis.
    Jersild C
    Birth Defects Orig Artic Ser; 1978; 14(5):123-70. PubMed ID: 99191
    [No Abstract]   [Full Text] [Related]  

  • 12. Measles-adherent lymphocyte phenomenon of Levy in multiple sclerosis: normal reactivity of blood lymphocytes.
    Kinnman J; Link H
    Acta Neurol Scand; 1979 May; 59(5):241-7. PubMed ID: 314219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of measles virus antigen on leukocyte migration in multiple sclerosis and controls.
    Kinnman J; Link H; Möller E; Norrby E
    Acta Neurol Scand; 1978 Nov; 58(5):261-71. PubMed ID: 216219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte stimulation in multiple sclerosis patients untreated and treated with transfer factor. Long-term studies on the effect of different stimulants on myo-(2-3H)inositol incorporation into phosphatidylinositol of lymphocytes.
    Offner H; Raun NE; Konat G; Fog T; Clausen J
    Acta Neurol Scand; 1977 Dec; 56(6):465-74. PubMed ID: 605771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfer factor in treatment of multiple sclerosis.
    Basten A; McLeod JG; Pollard JD; Walsh JC; Stewart GJ; Garrick R; Frith JA; Van Der Brink CM
    Lancet; 1980 Nov; 2(8201):931-4. PubMed ID: 6107585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: cellular and humoral immune responses to several viruses.
    Fuccillo DA; Madden DL; Castellano GA; Uhlig L; Traub RG; Mattson J; Krezlewicz A; Sever JL
    Neurology; 1978 Jun; 28(6):613-5. PubMed ID: 206860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current data on the etiopathogenesis of multiple sclerosis].
    Verdeş F
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir; 1977; 22(3):189-99. PubMed ID: 337441
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on the immune response in multiple sclerosis and other inflammatory diseases of the central nervous system.
    Kinnman J
    Acta Neurol Scand Suppl; 1981; 81():1-96. PubMed ID: 6939210
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of transfer factors in the treatment of multiple sclerosis: a case report.
    Sacks N; Potgieter HJ; Van Rensburg AJ
    S Afr Med J; 1976 Sep; 50(40):1556-8. PubMed ID: 982209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measles cellular immunity in patients with multiple sclerosis].
    Atanadze SN; Kodkind GKh; Smirnov YuK ; Khomak VIa; Veĭn AM
    Vopr Virusol; 1980; (2):166-9. PubMed ID: 6992452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.